Skip to main content
. 2022 Dec 14;37(4):595–603. doi: 10.1097/QAD.0000000000003462

Fig. 1.

Differences in the median CVD risk scores across inflammatory profiles relative to the reference cluster.

Fig. 1

95% confidence intervals are displayed. All three risk models adjusted for statin use. FRS and D:A:D also adjusted for ethnicity and BMI. D:A:D further adjusted for time since HIV diagnosis, nadir CD4+ cell count, years of ART use, and plasma HIV RNA load. CVD, cardiovascular disease; FRS, Framingham Risk Score; D:A:D, Data Collection on Adverse effects of anti-HIV Drugs.